ZBIO

ProShares UltraPro Short NASDAQ Biotechnology
ZBIO

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ZBIO was delisted on the 27th of March, 2020.

Back to rankings

3 hedge funds and large institutions have $934K invested in ProShares UltraPro Short NASDAQ Biotechnology in 2016 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

less capital invested

Capital invested by funds: $ → $

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

Holders
3
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$730K
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$352K

Top Sellers

1
-$1.78M
2
-$259K
3
-$21K
4
VF
Virtu Financial
New York
-$768
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$563K
2
$352K
3
$19K
4
–
5
–
6
–